Recent Updates
Recently added Catalysts
BMY Positive Sentiment

Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Wednesday, May 27, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Bristol Myers Squibb has announced its participation in the Goldman Sachs 47th Annual Global Healthcare Conference scheduled for June 9, 2026. The company will engage in a fireside chat at 2:00 p.m. ET, which will be accessible to investors and the public. An archived version of the session will be available post-event.
Price reaction · baseline $58.03 (2026-05-26 close) · hit pre-market · 1 other BMY headline(s) in the window, move may be shared
day 0 close · peak
-0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Bristol Myers Squibb is actively engaging with investors.
  • Participation in a prestigious healthcare conference highlights company visibility.
  • The event provides an opportunity for public engagement and transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+20%
120-day peak, hindsight
Typical move
1.7%
average across 15 past catalysts
Lead asset
Muraglitazar
Phase 3 · Type 2 Diabetes

Full Press Release Details

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Goldman Sachs 47thAnnual Global Healthcare Conference on Tuesday, June 9, 2026.
The company will take part in a fireside chat beginning at 2:00 p.m. ET.
Investors and the general public are invited to listen to the session by visitinghttp://investor.bms.com. An archived edition of the session will be available following its conclusion.
About Bristol Myers Squibb: Transforming Patients’ Lives Through ScienceAt Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us atBMS.comand follow us onLinkedIn,X,YouTube,FacebookandInstagram.
corporatefinancial-news

Frequently Asked Questions

When is the Goldman Sachs Healthcare Conference?

The conference is scheduled for June 9, 2026.

How can the public access the conference session?

The session can be accessed online at http://investor.bms.com.

What time will Bristol Myers Squibb's chat start?

The fireside chat will begin at 2:00 p.m. ET.

Will there be a recording of the session?

Yes, an archived edition will be available after the session concludes.

ShareAdd on Google
Tags: BMY Viatris Investor Conferences Healthcare Goldman Sachs healthcare conference investor relations Bristol Myers Squibb
Last updated: May 27, 2026

Biotech snapshot

Cash runway
$11464M liquidity · $0M/mo burn
Low dilution risk
Lead asset
MuraglitazarPhase 3
Type 2 Diabetes →

Catalyst track record

+20%
best trade around BMY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for BMY.

See every catalyst's timing & PoA →